The beta-lactone motif represents a new class of inhibitors for cysteine proteinases, specifically demonstrating irreversible inactivation of the HAV 3C proteinase.
Answers are grounded in this paper and cite their sources.
Beta-lactones may guide cysteine protease inhibitor design; leaves open antiviral applications pending higher-evidence studies.
[reaction: see text] N-Benzyloxycarbonyl-L-serine beta-lactone (1) is shown to irreversibly inactivate the 3C cysteine proteinase of hepatitis A virus (HAV) with k(inact) = 0.70 min(-1), K(I) = 1.84 x 10(-4) M and k(inact)/K(I) = 3800 M(-1) min(-1) at an enzyme concentration of 0.1 microM. Mass spectrometric and HMQC NMR studies using 13C-labeled 1 show that the active site cysteine (Cys-172) thiol of the HAV 3C proteinase attacks the beta-position (i.e. C-4) of the oxetanone ring, thereby leading to ring opening and alkylation of the sulfur. In contrast, the enantiomer of this beta-lactone, 2, is a reversible competitive inhibitor (Ki = 1.50 x 10(-6) M) at similar enzyme concentrations. The beta-lactone motif represents a new class of inhibitors of cysteine proteinases.
No takes yet. Share an insight, caveat, or question.
Lall et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: